MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company that is driven by scientific discovery and a commitment to patient care. The company specialises in delivering immunotherapies to treat a broad range of diseases, and operates in diverse geographical locales.
MoonLake Immunotherapeutics operates in the biopharmaceutical industry, aiming to use its targeted therapeutics to combat severe immune disorders. Its operations encompass research, development and the manufacturing of cutting-edge medicines.
Keep up to date on the latest share price changes by adding MLTX stock to your eToro watchlist.